| NCT ID | NCT07522866 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Emory University |
| Condition | Type1diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 48 participants |
| Start Date | 2026-07 |
| Primary Completion | 2028-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 48 participants in total. It began in 2026-07 with a primary completion date of 2028-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to learn whether a cognitive behavioral intervention can improve lifestyle and glucose targets for adults with type 1 diabetes.
Eligibility Criteria
Inclusion Criteria: * Aged 31 to 75 years * Type 1 Diabetes for at least 1 year * One or more sleep health dimensions are out of range Exclusion Criteria: * Non-English speaking * Recent night shift work or transmeridian travel * Life-limiting illness
Contact & Investigator
Stephanie Griggs, PhD, RN, FAAN
PRINCIPAL INVESTIGATOR
Emory University
Frequently Asked Questions
Who can join the NCT07522866 clinical trial?
This trial is open to participants of all sexes, aged 31 Years or older, up to 75 Years, studying Type1diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07522866 currently recruiting?
Yes, NCT07522866 is actively recruiting participants. Contact the research team at stephanie.griggs2@emory.edu for enrollment information.
Where is the NCT07522866 trial being conducted?
This trial is being conducted at Atlanta, United States, Atlanta, United States.
Who is sponsoring the NCT07522866 clinical trial?
NCT07522866 is sponsored by Emory University. The principal investigator is Stephanie Griggs, PhD, RN, FAAN at Emory University. The trial plans to enroll 48 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.